Sandra Milligan

Insider Reports History

Location
San Diego, CA
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sandra Milligan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Organon & Co. Head of Research & Development Common Stock 28,599 $615,736 $21.53 04 May 2023 Direct
Gossamer Bio, Inc. Director Common Stock 58,050 $111,456 $1.92 19 Aug 2025 Direct
Organon & Co. Head of Research & Development Restricted Stock Units 4,984 $107,306 $21.53 04 May 2023 Direct
Aspira Women's Health Inc. Interim CEO Stock option (right to buy) 25,000 $96,000 $3.20 12 Nov 2024 Direct
Aspira Women's Health Inc. Interim CEO Common Stock 13,644 $9,551 $0.7000 08 Jan 2025 Direct
Aspira Women's Health Inc. Interim CEO Restricted Stock Units 0 $0 $2.42 31 Dec 2024 Direct
Gossamer Bio, Inc. Director Stock Option (Right to Buy) 115,000 25 Jun 2025 Direct
Spyre Therapeutics, Inc. Director Stock Option (Right to Buy) 25,000 29 May 2025 Direct

Insider Reports Filed by Sandra Milligan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GOSS Gossamer Bio, Inc. 19 Aug 2025 1 +$50,016 4 Director 20 Aug 2025, 16:04
GOSS Gossamer Bio, Inc. 25 Jun 2025 1 $0 4 Director 26 Jun 2025, 16:36
SYRE Spyre Therapeutics, Inc. 29 May 2025 1 $0 4 Director 02 Jun 2025, 16:37
AWHL Aspira Women's Health Inc. 31 Dec 2024 3 -$4,449 4/A Interim CEO 29 Jan 2025, 17:20
AWHL Aspira Women's Health Inc. 12 Nov 2024 1 $0 4 President 13 Nov 2024, 20:54
AWHL Aspira Women's Health Inc. 28 Oct 2024 1 $0 4 President 28 Oct 2024, 18:54
GOSS Gossamer Bio, Inc. 06 Jun 2024 1 $0 4 Director 06 Jun 2024, 21:58
SYRE Spyre Therapeutics, Inc. 14 May 2024 1 $0 4 Director 16 May 2024, 16:10
SYRE Spyre Therapeutics, Inc. 14 May 2024 0 $0 3 Director 16 May 2024, 16:05
AWHL Aspira Women's Health Inc. 03 May 2024 1 $0 4 President 06 May 2024, 18:49
AWHL Aspira Women's Health Inc. 01 Apr 2024 0 $0 3 President 04 Apr 2024, 19:27
GOSS Gossamer Bio, Inc. 15 Nov 2023 1 +$25,213 4 Director 17 Nov 2023, 16:01
GOSS Gossamer Bio, Inc. 08 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:14
OGN Organon & Co. 04 May 2023 3 -$52,552 4 Head of Research & Development 08 May 2023, 18:43
OGN Organon & Co. 01 May 2023 3 -$20,344 4 Head of Research & Development 03 May 2023, 19:06
OGN Organon & Co. 31 Mar 2023 5 -$48,835 4 Head of Research & Development 04 Apr 2023, 20:18
OGN Organon & Co. 28 Feb 2023 3 -$58,861 4 Head of Research & Development 02 Mar 2023, 16:29
GOSS Gossamer Bio, Inc. 09 Jun 2022 1 $0 4 Director 15 Jul 2022, 17:03
OGN Organon & Co. 03 May 2022 6 -$75,429 4 Head of Research & Development 05 May 2022, 20:47
OGN Organon & Co. 01 May 2022 3 -$17,458 4 Head of Research & Development 03 May 2022, 19:40
OGN Organon & Co. 31 Mar 2022 2 $0 4 Head of Research & Development 04 Apr 2022, 18:06
OGN Organon & Co. 28 Feb 2022 3 -$110,493 4 Head of Research & Development 02 Mar 2022, 17:46
OGN Organon & Co. 17 Aug 2021 1 $0 4 Head of Research & Development 19 Aug 2021, 17:14
GOSS Gossamer Bio, Inc. 10 Jun 2021 1 $0 4 Director 14 Jun 2021, 17:26
GOSS Gossamer Bio, Inc. 10 Jun 2021 0 $0 3 Director 14 Jun 2021, 17:21
OGN Organon & Co. 02 Jun 2021 12 $0 4 Head of Research & Development 04 Jun 2021, 21:27
OGN Organon & Co. 02 Jun 2021 0 $0 3 Head of Research & Development 02 Jun 2021, 17:48